Related by context. All words. (Click for frequent words.) 72 Eugene Braunwald MD 67 Laura Mauri 67 Pediatric Neurological Surgery 66 Mitchell Krucoff 66 Dr. Jeffrey Peipert 66 MEND CABG 65 Gabriel Hortobagyi MD 65 Hertzel Gerstein 65 Nutritional Metabolism 65 Andrew Feigin 65 M.D. Ph.D. 64 CARE HF 64 Cholesterol Levels SPARCL 64 Hospitals Leuven Belgium 64 INSPIRE Trial Phase III 64 Monique MB Breteler 64 J Am Coll 64 Kimmie Ng 64 Professor Eberhard Grube 64 Telik Announces 64 Randomized Double blind 64 Bradley Boeve 63 Gastrointestinal Oncology 63 Joseph Loscalzo 63 Georges Gemayel 63 FACC FAHA 63 Andre Terzic 63 MPP MPH 63 RE LY 63 Carotid Revascularization Endarterectomy vs. 63 ExTRACT TIMI 63 Ele Ferrannini 63 FACR 63 Demonstrates Sustained 63 Dr. Eugene Braunwald 63 First Patient Enrolled 63 Sven Cnattingius 63 Werner Hacke 63 Aggressive Reduction 62 STRIDE PD 62 ThermoDox ® clinical 62 Phase 2b Clinical Trial 62 ACRIN 62 Edward Giovannucci 62 FOLFOX6 chemotherapy regimen 62 Platelet Inhibition 62 Amir Lerman 62 See CLINICAL PHARMACOLOGY 62 number NCT# ClinicalTrials.gov 62 George Coukos 62 John JP Kastelein 62 Pediatric Oncology Branch 62 #:#-#,# CrossRef Medline [002] 62 Ben Slotman 62 Tamas Horvath 62 undergoing elective percutaneous 62 Mien Chie Hung 62 ANN INTERN MED 62 Eugene Flamm 62 ALN HPN 62 Jean Claude Tardif 62 Meets Primary Endpoint 62 Am J Geriatr 62 Thomas Südhof 62 Gilles Montalescot 62 Irwin Olian Irwin Olian 62 UCSF Headache Center 62 pralatrexate injection folate analogue 62 Marc Sabatine 62 Monica Mita 62 evaluate ZFP Therapeutic 62 Michael Leitzmann 62 Gregory A. Demopulos 61 Mihael Polymeropoulos MD 61 Celecoxib APC trial 61 Neuro Oncology Program 61 #:#-# [024] 61 Lipid Lowering Treatment 61 EnVivo Pharmaceuticals Inc. 61 Translational Biology 61 Elizabeth Selvin 61 PRESEPT 61 Immunotherapeutic 61 Eckard Weber 61 TRA 2P 61 R lenalidomide 61 Val HeFT 61 Intervention Effectiveness 61 Developmental Therapeutics 61 Cardiovascular Epidemiology 61 PLX STROKE targeting 61 Women Ischemia Syndrome 61 Combination REOLYSIN R 61 Evaluation WISE 61 Virend Somers MD Ph.D. 61 Clinical Antipsychotic Trials 61 Gastroenterology Hepatology 61 CHARISMA trial 61 MD MHSc 61 Michael F. Leitzmann 61 Hematologic Malignancies 61 malignant mesothelioma Alfacell 61 Edge STudy 61 Double Blind Placebo 61 Steven Ratoff 61 MassGeneral Institute 61 Adenoma Prevention 61 Luigi Ferrucci 61 Thoraxcenter Erasmus University 61 Cornea Donor Study 61 HNRCA 61 Prospective Randomized 61 REALITY Trial 61 Matthew Meyerson 61 J Clin 61 #rd Annual CTRC 60 Preclinical Study 60 Initiates Phase III 60 E. Magnus Ohman 60 Surgery Urology 60 Paul Laikind 60 Cardiol 60 Interventional Vascular Therapy 60 #-# Full Text 60 Phase 2b Trial 60 EDEMA3 trial 60 FMedSci 60 J Am Acad 60 candesartan cilexetil 60 Phase III multicenter 60 CALGB # [002] 60 Alan Menter 60 Refractory Angina 60 Eric Kossoff 60 Nutrition Metabolism 60 Dr. Hagop Kantarjian 60 Vascular Medicine 60 Oral Fingolimod 60 NSABP 60 RECORD1 60 Study Evaluating 60 Acute Exacerbations 60 Spiro Rombotis President 60 MAGE A3 ASCI 60 Dr. Philip Toleikis 60 ATACAND 60 Phase 1b clinical trials 60 Genitourinary Oncology Service 60 FASN 60 Stevo Julius 60 Stephen Coggeshall 60 High Throughput Biology 60 HYVET 60 Colin Baigent 60 J. Mazzo Ph.D. 60 ENDEAVOR IV 60 Nalini Ranjit 60 CYT# potent vascular disrupting 60 coronary stent merged 60 Lynda Chin 60 NASH CRN 60 SCAI Annual 60 CombAT 60 Rando Allikmets 60 Juergen Engel Ph.D. 60 Xcytrin R 60 BARI 2D 60 DMD DMSc 60 Patrick W. Serruys 60 ETB Full Bio 60 Arno Therapeutics 60 pentadentate logo R 60 Urologic Oncology 60 Digital Mammographic Imaging 60 Pulmonary Allergy 60 pharmacogenomic translational research 60 Crofelemer budesonide foam 60 Sc.M. 60 MEND CABG II 60 Prostate Lung Colorectal 60 evaluating Actimmune 60 Christoph Westphal MD Ph.D. 60 Philip Poi 60 IMiDs ® compound 60 Initiate Phase 60 Kuvan sapropterin dihydrochloride 60 peripheral arterial occlusive disease 60 Hagop M. 60 Anders Sundstrom 60 HDL Selective Delipidation 60 Free Full Text 60 myocardial infarction ventricular fibrillation 60 Piero Anversa 60 Randomized Evaluation 60 JAK2 Inhibitor 60 AACR IASLC Joint 60 kidney urologic 60 ONTARGET 60 Pivotal Trial 60 Per Olof Wallström 59 Cardiovascular Outcomes 59 evaluating tivozanib 59 Arch Neurol 59 Sangamo BioSciences Announces 59 Levels Linked 59 Amy Abernethy 59 CALGB 59 Cancer Incidence Mortality 59 landmark ATHENA 59 Functional Neurosurgery 59 Glickman Urological 59 #:#-#,# Medline 59 Clinical Outcome 59 CALERIE 59 Richard Nesto 59 deCODE AF TM 59 Completes Patient Enrollment 59 J Cataract Refract 59 sulodexide 59 Phase Ib Clinical Trial 59 REVIVE Diabetes 59 Jean Pierre Sommadossi Ph.D. 59 Ophthalmic Drugs Advisory 59 EchoCRT 59 EEG abnormalities 59 Venous Thromboembolism 59 receiving chemoradiation therapy 59 TEI Biosciences 59 BZA CE 59 Ueno founded 59 K. Javeed Nayeem 59 Patients Treated With 59 Paroxysmal Nocturnal Hemoglobinuria PNH 59 Glucosamine Chondroitin Arthritis 59 biostatistical analysis 59 Eva Schernhammer 59 bronchospasm dizziness headache 59 Advanced Melanoma 59 Demonstrates Efficacy 59 Breaking Clinical Trials 59 TG MV 59 Acute Coronary Syndromes 59 Dr. Ayalew Tefferi 59 Ann Oncol 59 multicenter Phase II 59 Oral Presentation # 59 Aravinda Chakravarti Ph.D. 59 Diabetes Interventions 59 Patrick Serruys 59 Bowel Project NSABP 59 Gerold Bepler MD Ph.D. 59 Diabetic Macular Edema 59 ENDEAVOR III 59 Ph.D. D.Sc. 59 Knee Osteoarthritis 59 Guillermo Torre Amione 59 APPRAISE 59 AIR2 Trial 59 By JENNIFER LEARN 59 #:#-#,# [002] 59 MD ScD 59 recurrent malignant glioma 59 National Surgical Adjuvant 59 vitro pharmacology 59 Barry D. Quart 59 EMPOWER ™ 59 Screening Trial 59 DIRECT Trial 59 Philip Mease 59 Judith Hochman 59 TO AVOID PREGNANCY WHILE 59 PEARL HF 59 Prospective Multicenter 59 Am J Obstet 59 Acute Pain 59 David Sidransky 59 Septin9 biomarker 59 Eur J 59 intracranial atherosclerosis 59 Eugene Braunwald 59 #:#-#,# CrossRef Medline [001] 59 Alexandre Abizaid 59 Clinical Efficacy 59 Carotid Stenting 59 M. Ridker 59 J Child Adolesc 59 J Shoulder Elbow 59 J. Clin 59 Hematological 59 Vasc 59 Laurence Klotz 59 PROSTASCINT R 59 Zenvia ™ 59 Bianca Weinstock Guttman 59 Contributing Editor JAMA 59 EnVivo Pharmaceuticals 59 FSCAI 59 MD Sc.D. 59 Mark A. Sirgo 59 John G. McHutchison 59 vapreotide acetate 59 fosbretabulin 59 PJ Devereaux 59 ARCOXIA 59 MGd 59 MGH MIND 59 hyperphenylalaninemia HPA due 59 Lita Annenberg Hazen 59 IL# PE#QQR 59 ST Segment Elevation 59 By Karen Pallarito 59 Shane Ebert P.Geo 59 Zeuzem 59 TRANSDUR ® 59 Gynecologic Oncology Group 59 Channing Laboratory 59 Ichiro Kawachi 59 By Kathleen Doheny 59 Dr. Gabriella Gobbi 59 Jacob Inbar 59 Carl Spana Ph.D. 59 CYP#A# CYP#D# 59 MD FAHA 59 Romidepsin 59 Raymond T. Bartus 59 Alvine Pharmaceuticals 58 Services #:#-#,# Abstract 58 Iris Loew Friedrich 58 Initiates Enrollment 58 J Consult Clin 58 Dariush Mozaffarian 58 FOLOTYN ® 58 Clinical Trial Data 58 Cutaneous Oncology 58 Endometrial 58 MD PhD Professor 58 Dr. Ihor Gussak 58 Trandolapril 58 Tom Misteli 58 II Clinical Trial 58 MD Dr.PH 58 ScD MPH 58 Srdan Verstovsek 58 PharmD Ardea 58 Circulatory Support 58 PANVAC VF 58 Postdoctoral Position 58 aripiprazole Abilify 58 novel VDA molecule 58 Sebastian Schneeweiss 58 Antiplatelet 58 signal detection CTSD 58 GEM OS2 58 controlled multicenter Phase 58 Mg Usa 58 Demonstrates Positive 58 Markus Heilig 58 Reperfusion Injury 58 lexidronam injection 58 Jose Baselga 58 Gerald Andriole MD 58 non valvular atrial 58 CAPRIE 58 Kathleen Merikangas 58 Jacques Genest 58 Orqis Medical 58 Patrice Milos 58 Steven Nissen MD 58 Eric Van Cutsem 58 Kidney Transplant Patients 58 Hematology Molecular Pathology 58 Karl Heinz Kuck 58 NATRECOR ® 58 By Ed Edelson 58 Molecular Cardiology 58 Kenneth M. Borow 58 events thrombocytopenia neutropenia 58 Fondaparinux 58 Pediatric Rheumatology 58 Anesthesiology Critical Care 58 Ole Isacson 58 intravesical infusion therapy 58 Francesca Bravi 58 Zeb Horowitz 58 USDA HNRCA 58 Postmenopausal Women 58 Dialysis Outcomes 58 PFO migraine 58 Infect Dis 58 SPARCL 58 Acute Treatment 58 Novel Oral 58 Tezampanel 58 Telik logo TELINTRA 58 Paul G. donohue 58 oral antidiabetic medication 58 Endothelial Function 58 DMSc 58 Teriflunomide 58 Current Author Addresses 58 CHAMPION PCI 58 John R. Plachetka 58 Tim Coughlin MAusIMM 58 ACTEMRA TM 58 prostate carcinogenesis 58 ST Elevation Myocardial 58 headache nasopharyngitis 58 Wadih Arap 58 Distinguished Hersey 58 J. Ursano 58 Tasigna prolongs 58 Urocortin 2 58 Gentium Announces 58 By Alan Mozes 58 Crit Rev 58 Demonstrates Significant 58 Karolinska Institute Stockholm Sweden 58 Occlusive Disease 58 DNA methyltransferase inhibitors 58 undergone radical prostatectomy 58 Braunwald 58 Institute DCRI 58 Am J Clin 58 Prolongs Survival 58 Joshua Boger Ph.D. 58 HORIZONS AMI 58 oral Janus kinase 58 FDA APPROVES 58 IMiDs R 58 commercialize CorMedix drug 58 Roberto Bolli 58 Tobias Kurth 58 Hakon Hakonarson 58 Phase III ADT 58 TEMSO 58 SinuNase ™ 58 Elazer Edelman 58 Clin Chem 58 Unstable Angina 58 Jean Francois Rossignol 58 AA Amyloidosis 58 Laurence Birch DATATRAK 58 Alastair Compston 58 chromium supplementation 58 MD DrPH 58 By Steven Reinberg 58 Prof. Pnina Fishman 58 Psychosocial Aspects 58 Alpha Tocopherol Beta Carotene 58 Author Affiliation 58 Cascade LifeSciences 58 Monique Breteler 58 By EJ Mundell 58 AMEX RGN 58 Serostim ® 58 FRCPath 58 THAT ARE DIFFICULT TO 58 Left Ventricular Dysfunction 58 Antihypertensive 58 Empatic ™ 58 MERLIN TIMI 58 Budesonide foam crofelemer 58 #:#-#,# CrossRef 58 LibiGel Phase III 58 Martinos Center 58 chronic thromboembolic pulmonary 58 Joseph K. Belanoff 58 CHARM Added 58 J Foot Ankle 58 REACH Registry 58 Poordad 58 Daniel Von Hoff 58 serum leptin 58 Evaluation Program CTEP 58 Controlled Study 58 Sudhir Agrawal D.Phil 58 Ovitrelle R Serostim 58 ATRA IV 58 Cervical Dysplasia 58 Long Term Efficacy 58 diabetes sciatica 58 anaphylactic reactions bronchospasm 58 R MSCRAMM 58 Steven R. Deitcher 58 Cardium Therapeutics TM 58 Sudha Seshadri MD 58 Survivorship Program 58 Heart Failure Patients 58 Syncria R 58 J.P. Morgan Healthcare 58 Mr. Zhenjiang Yue 58 RE LY ® 58 Joseph Ragaz 58 Thiazolidinediones 57 Integrative Neurosciences 57 Abiraterone Acetate 57 Experimental Therapeutics Program 57 Gonzague Issenmann 57 LibiGel ® 57 Controlled Trial 57 Nicholas Borys 57 Surgical Treatment 57 Hypertensive adverse reactions 57 PERSEUS clinical program 57 Bipolar Disorders 57 Gabriel N. Hortobagyi 57 WEB OF SCIENCE 57 Warfarin Coumadin 57 Neil Scolding 57 Therapeutics TCT scientific 57 Elena Losina 57 Addrenex Pharmaceuticals 57 BioNumerik 57 Chang Ahn Rexahn 57 Dr. Rochelle Dicker 57 Gabriel Zada neurosurgeon 57 Gynecol 57 PRIMO CABG2 57 BCG refractory carcinoma 57 Demonstrate Significant 57 Professor Hardev Pandha 57 Zorbtive TM 57 known dihydropyrimidine dehydrogenase 57 Beatrice Golomb 57 Trial Evaluating 57 KM Venkat Narayan 57 COU AA 57 Randomized Double Blind Placebo 57 metaglidasen 57 Stenting Trial CREST 57 plus Copegus R 57 Ph.D. Targacept 57 Mr. Armando Anido 57 atypical Hemolytic Uremic Syndrome 57 EVEREST II 57 Solid Tumor 57 Acute Myocardial Infarction 57 Diabetes Endocrinology 57 Gastric Cancer 57 Cardiac Arrhythmia Service 57 Graham Archard 57 Metastatic Melanoma 57 catheter occlusion 57 Anat Cohen Dayag 57 Claudia Henschke 57 Uterine Cancer 57 MD M.Sc. 57 Pivotal Phase II 57 Dose Ranging Study 57 Group RTOG 57 Phase IIb Clinical Trial 57 Acute MI 57 Armen PhD 57 Mayo Clinic urologist 57 Antigen Specific 57 Includes KCI proprietary 57 #:#-#,# [003] 57 memantine HCl 57 Cardiovascular Magnetic Resonance 57 Myocet 57 Hakan Edstrom 57 Gheorghiade 57 Howard H. Pien 57 interferon gamma 1b 57 novel orally inhaled 57 Arthur Beaudet 57 Author Affiliations Division 57 thetreatment 57 Phase #b/#a clinical 57 Steven B. Ratoff 57 GERD migraine headaches 57 Nickolas Papadopoulos 57 constipation predominant irritable bowel 57 please visit www.brighamandwomens.org 57 Bruce Spiegelman 57 Am J Epidemiol 57 induce orthostatic hypotension 57 Dr. Hyon Choi 57 immunomodulatory agents 57 Gil Mor 57 H. Erich Wichmann 57 Physiology Seminar 57 NIAAA Laboratory 57 Jonathan Berek 57 visit www.aan.com 57 Patrik De Haes 57 Investigational Drug 57 Robin Yabroff 57 Operative Dentistry 57 John C. Ruckdeschel 57 Zami Aberman 57 prospective multicentre 57 Charis Eng 57 Celine Vachon 57 Clive Svendsen 57 myelodysplastic myeloproliferative diseases 57 Female Urology 57 Investigational Treatment 57 CLARITY TIMI 57 Robert Siliciano 57 Arch Facial Plast 57 Adrian Di Bisceglie 57 Meta Analysis 57 Breast Oncology 57 Acute Liver Failure 57 sorafenib Nexavar 57 Fondazione IRCCS Istituto Nazionale 57 Wijns 57 Intervention Trial GAIT 57 Dr. Fahar Merchant 57 Randomized Double Blind 57 D. Von Hoff 57 NABTT 57 colesevelam HCl 57 Cell Transplant 57 Consultant Paediatric 57 Maven Semantic 57 Ocrelizumab 57 Lankenau Institute 57 Brown B.Sc. MBA 57 SABCS 57 Biomolecular Medicine 57 Craniofacial Pain 57 Fred Eshelman PPD 57 Dana-Farber/Children s Hospital 57 Peter Le Couteur 57 Proc Am Soc 57 CrossRef Medline 57 Salim Yusuf 57 IMPACT DCM 57 JOHN HONG 57 Dick Hipple 57 candidates Augment ™ 57 oral deforolimus 57 C. Warren Olanow 57 Cardiovascular Radiology 57 granted Ortec 57 phase IIb study 57 Chain Intellect 57 brivaracetam 57 Alan Dangour 57 Raloxifene Evaluation MORE 57 EXPLORE Xa 57 FUSILEV enhances 57 Rowan T. Chlebowski 57 Metabolic Disease 57 Charles Hoge colonel 57 pancreas esophagus 57 relapsed MM 57 Dr. Steven Burakoff 57 Lars Sjostrom 57 AAG geldanamycin analog 57 Remission Maintenance 57 Dr Ananya Mandal 57 Haim Aviv 57 included exfoliative dermatitis 57 Vita Salute San 57 multicenter phase 57 J Am Soc 57 neurology neuroscience 57 FRACP 57 University Vita Salute 57 psoriatic arthritis PsA 57 recurrent metastatic ovarian cancer 57 HCl PEPCID ® famotidine 57 worsening thrombocytopenia 57 Phase III Clinical Trial 57 Mark Sirgo 57 Bruce Psaty 57 severe hypercholesterolemia 57 Cerebril TM 57 personalized cellular immunotherapy 57 Patient Outcomes 57 Urologic Surgery 57 BY EDWARD ZERIN 57 MBA EntreMed 57 Recurrent Breast Cancer 57 By Neil Osterweil 57 Dr. Gianni Belcaro 57 Dr. Suraj Achar 57 Cardiac Imaging 57 Lung Injury 57 Interventional Neuroradiology 57 AVAPRO 57 Procyon Biopharma 57 Randomized Phase II 57 Verstovsek 57 Chronic Heart Failure 57 Multicenter Phase 57 Timothy Botello 57 BY WILLA J. 57 Hormone Refractory Prostate Cancer 57 Ryuji Ueno 57 Syndax 57 Experimental Therapeutics 57 Harry Palmin President 57 PROSTVAC VF 57 bazedoxifene conjugated estrogens 57 Charles Brempong Yeboah 57 Pivotal Phase 57 G. d' Annunzio 57 Atul Singhal 57 metastatic castration resistant 57 J. Edward Puzas 57 Ovarian PLCO Cancer 57 Slows Progression 57 phase IIa clinical 57 Chicago Multidisciplinary Symposium 57 author Xiang Gao 57 Severe Sepsis 57 Hem Pandya 57 EXECUTIVE SUMMARY II 57 Granted Orphan Drug 57 Sleep Disturbances 57 Geert Cauwenbergh Ph.D. 57 Clinical Evaluation 57 Neuropharmacology 57 Vaccine Protects Against 57 TRO# 57 gefitinib Iressa 57 noninvasive outpatient 57 JJ Finkelstein 57 ASCO GI 57 Fred Kavalier 57 ELACYT 57 phase IIb clinical 57 Inflammatory Markers 57 Phase 2b Study 57 Pooled Analysis 57 ibuprofen diclofenac 57 Arul M. 57 Drug Prevents 57 Dermatol 57 lucinactant 57 Endocrine Society #st 57 Ronald DePinho 57 Outpatient Setting 57 Cheryl Bushnell 57 Pediatric Psychopharmacology 57 Intervention Effectiveness CATIE 57 Submits NDA 57 Dose Escalation 57 Bone Augmentation Material 57 evaluating T DM1 57 Bone Metabolism 57 Clinical Trial Results 57 multicenter randomized clinical 57 antidiabetic drug 56 HMG CoA reductase inhibitors 56 prospective randomized placebo 56 Aflibercept 56 Hyperlipidemia 56 #:#-# [023] 56 Bradbury Amylin 56 CIMZIA TM certolizumab pegol 56 Ph.D. GTC 56 Nat Genet 56 YOUR LOCAL ANIMAL SHELTER 56 Multicenter 56 Curr Opin 56 Myrna Weissman 56 #:#-# [007] 56 James Cerhan MD 56 atherosclerotic CVD 56 Topline Results 56 Elocalcitol 56 Pivotal Phase III 56 read Palintologist 56 Diabetic Neuropathy 56 AACR San Antonio 56 Experimental Neurology 56 Pier Paolo Pandolfi 56 PARC MGH 56 Thrombolysis 56 myelofibrosis polycythemia vera 56 Antitumor Activity 56 Multiple Ascending Dose 56 T. Felson 56 Cortoss TM 56 Cancer Immunotherapy 56 DCCT EDIC 56 Diamyd Medical Diamyd 56 J Antimicrob Chemother 56 prospective nonrandomized 56 Veronate R 56 Randomized Clinical Trial 56 Asher Chanan Khan 56 CURE AF 56 Gary Ghiselli 56 MULLIGAN FAMILY FUN CENTER 56 HCV Protease Inhibitor 56 M. Bradbury Amylin 56 Medidur TM FA 56 Karl Swedberg 56 Drug Shows Promise 56 Alfred I. Neugut 56 Jon Kar Zubieta 56 macrovascular events 56 Gastrointestinal Cancers 56 Hematological Malignancies 56 Left Ventricular Hypertrophy 56 TRANSDUR ™ 56 PDX pralatrexate 56 Everist Genomics 56 Pharmacother 56 Alzheimer Disease Cooperative 56 Kalantar Zadeh 56 Alseres Cethrin 56 Bassam Damaj Ph.D. 56 Islet Transplantation 56 retinal vein occlusion induced 56 W. Naranja 56 IIa clinical 56 Personalized Immunotherapy 56 Hagop Kantarjian MD 56 selective modulator 56 MBBS Ph.D. 56 Nephrol Dial Transplant 56 Urology Gynecology 56 Brant Zawadzki 56 Wayne Katon 56 MD MSc 56 Hsp# Inhibitor 56 PON1 activity 56 Randomized Comparison 56 VARI Laboratory 56 Candace Kendle PharmD 56 By Jenifer Goodwin 56 Prednisone Against Refractory 56 Kandzari 56 trial evaluating PRX# 56 Acute Decompensated Heart Failure 56 TLK# 56 Thoraxcentre Erasmus University 56 Patricia Hartge 56 Vertebral Fractures 56 Brian JG Pereira 56 tW.tW.I. 56 Safinamide 56 Dr. Kandzari 56 Late Breaker 56 endometriosis ovarian cysts 56 Attending Surgeon 56 elotuzumab 56 Clin J 56 Bengt Winblad 56 Cerebral Amyloid Angiopathy 56 Endologix Powerlink System 56 Inflammatory Diseases 56 Cellular Oncogenesis Program 56 post herpetic 56 Phase IIa Clinical Trial 56 First Patient Dosed 56 Simin Nikbin Meydani 56 Patients Undergoing 56 Synta Announces 56 Wendie Berg 56 Cardiovascular Disease Prevention 56 Ischemic 56 ACCOMPLISH 56 multicenter prospective 56 TRITON TIMI 56 Gregory D. Casciaro 56 Jim DeMesa 56 Kathleen Danenberg 56 Peripheral Arterial 56 LUX Lung 56 JD Avigen 56 CCCEH 56 Harold D. Stolovitch 56 Nicotine Vaccine 56 George Ebers 56 Teva Provides Update 56 Investigational Compound 56 AGAF 56 Tod Woolf Ph.D. 56 UEGW 56 Kieran Downes P.Geo 56 SUTENT ® 56 RIO Lipids 56 multicenter placebo controlled 56 Hunt Batjer 56 Dr. Kantarjian 56 Mayo Clinic oncologist 56 Heather Eliassen 56 EMBO J. 56 Multiethnic Study 56 Sidney Kimmel Comprehensive Cancer 56 acute humoral rejection 56 NATRECOR R 56 Environ Health Perspect 56 Spirus Medical 56 ONCONASE R 56 mason@knews.com 56 Sc.D. MPH 56 atherogenic dyslipidemia 56 Diabetic Foot Ulcer 56 Truvada tablets 56 ELADUR ™ 56 Systemic Sclerosis 56 Phase 1b Clinical Trial 56 unfractionated heparin UFH 56 Arthritis Musculoskeletal 56 ACNP 56 VIVUS Announces 56 Stacy Tessler Lindau 56 oral ghrelin agonist 56 BCIRG 56 ENESTnd 56 PEGINTRON TM 56 Morgan J. Poliquin 56 Phase Ib IIa 56 ADVANCE PD 56 LOW PRICE STOCK 56 BUSM 56 Bronchiectasis 56 Acute Ischemic Stroke 56 Entereg TM 56 Inflammatory Arthritis 56 familial amyloidotic polyneuropathy FAP 56 budesonide MMX Phase III 56 Augment TM 56 Ron Bentsur 56 Randomized Phase 56 Aliskiren 56 Phase III AFFIRM 56 OSUCCC 56 Reduces Mortality 56 Nonalcoholic Steatohepatitis 56 Fetal Fibronectin Test 56 Adjuvant Chemotherapy 56 CINQUIL 56 Cancer Cachexia 56 Levi Garraway 56 Lars Wallentin 56 Louis Kavoussi 56 Metabolic Medicine 56 IN PATIENTS WITH 56 Atherosclerosis Research 56 viral kinetic 56 Multicentre 56 GOUT 56 HeFH 56 Biomarker Study 56 Arch Surg 56 aMCI precursor 56 Ischemic Stroke 56 Neurologic Diseases 56 Mr. Xiaodong Wu 56 J. Drachman 56 Phase 2a Clinical Trial 56 Anti Bacterial Envelope 56 Consultant Haematologist 56 Scott Fridkin 56 MD Moross Institute 56 Heterozygous Familial Hypercholesterolemia 56 Group B CALGB 56 Mouse Models 56 confirmatory clinical 56 Mark Pykett 56 JoAnn Manson 56 Improve Diagnosis 56 multicenter trials 56 Kathy Wolski 56 Genitourinary 56 experimental therapeutics 56 papillary renal cell carcinoma 56 #-THOUSAND DOLLAR 56 Honorary Consultant 56 James M. DeMesa 56 Transplantation Immunology 56 multicenter randomized controlled 56 Lenore Launer 56 iSBTc 56 ECASS 56 Arteriosclerosis Thrombosis 56 Jon Faiz Kayyem 56 RNAi Therapeutic 56 DFCI 56 Soft Tissue Sarcoma 56 Blum Cytokinetics 56 Eunyoung Cho 56 Initiate Clinical Trial 56 Maria Karayiorgou 56 Index SPI SPIEX 56 Cell Sci 56 Renata Pasqualini 56 Biomerix Corporation 56 Lumbar Spine 56 Tony Milici 56 Pharmacokinetic Pharmacodynamic 56 Jeffrey H. Buchalter 56 Michele Heisler 56 GATTEX TM 56 Paul Thornalley 56 Diana Schendel 56 Patrick Fourteau 56 Kevin Niswender 56 SIMCOR